Inactive Instrument

All News INSTEM

Equities

Instem and Proscia Partners to Accelerate Preclinical Development with Digital Pathology	06-17	CI
Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline	01-25	CI
Instem Delists from London Bourse's AIM After Merger with ArchiMed	11-21	MT
France's Archimed Completes Acquisition of UK's Instem	11-20	MT
Instem plc Announces Board Resignations	11-20	CI
ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers.	11-19	CI
Instem acquisition by Ichor sanctioned by UK court	11-16	AN
Instem : Issue of Equity, PDMR Dealings and Rule 2.9 Announcement	11-16	PU
UK Court Clears Archimed’s Takeover of Instem	11-16	MT
Samson Rock Capital LLP - Form 8.3 - Instem Plc	11-15	PR
Samson Rock Capital LLP - Form 8.3 - Instem Plc	11-13	PR
Samson Rock Capital LLP - Form 8.3 - Instem Plc	11-10	PR
Samson Rock Capital LLP - Form 8.3 - Instem Plc	11-09	PR
Actual Experience appoints administrators	11-07	AN
Instem's Acquisition by Archimed's Ichor Management Granted UK Regulatory Nod	11-07	MT
Samson Rock Capital LLP - Form 8.3 - Instem Plc	11-06	PR
Instem shareholders back motions relating to Archimed offer	11-03	AN
Samson Rock Capital LLP - Form 8.3 - Instem Plc	11-03	PR
Instem, Archimed’s Ichor Management Agree Acquisition Deal Price	30/10/23	MT
Instem : Adjournment of the Court Meeting and General Meeting	20/10/23	PU

No results for this search